Current progress and future trends in nanoparticle applications for lymphoma: a bibliometric analysis from 2004 to 2024.

Discov Oncol · 2025 · PMC12748484 · PMID 41258620

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

The bibliometric evidence supports this shift, indicating a strong trend toward the convergence of material science and adoptive cell therapy in the pursuit of next-generation lymphoma treatments.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.